Compare SCLX & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | BRFH |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.9M | 46.6M |
| IPO Year | N/A | 2010 |
| Metric | SCLX | BRFH |
|---|---|---|
| Price | $6.57 | $2.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 30.1K | 3.1K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $211,467.00 |
| Revenue This Year | N/A | $37.56 |
| Revenue Next Year | $749.70 | $101.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 92.09 |
| 52 Week Low | $0.18 | $2.00 |
| 52 Week High | $34.27 | $6.08 |
| Indicator | SCLX | BRFH |
|---|---|---|
| Relative Strength Index (RSI) | 30.61 | 49.31 |
| Support Level | $4.56 | $2.55 |
| Resistance Level | $7.50 | $3.47 |
| Average True Range (ATR) | 0.64 | 0.14 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 0.00 | 58.06 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.